PodClips Logo

If we're really talking about reducing ApoB to the levels that we call physiologic, that's really going to be the application of pharmacotherapy.
0:30
Peter Attia

Lowering ApoB Is Like Slowing Down a Race Car Headed Toward a Cliff

AMA #43: Understanding apoB, LDL-C, Lp(a), and insulin as risk factors for cardiovascular disease

The Peter Attia Drive

Topic: moment

Lowering ApoB Is Like Slowing Down a Race Car Headed Toward a Cliff

Lowering ApoB Is Like Slowing Down a Race Car Headed Toward a Cliff

AMA #43: Understanding apoB, LDL-C, Lp(a), and insulin as risk factors for cardiovascular disease - Peter Attia
0:00
5:33
left arrow
0:00
5:33
Lowering ApoB Is Like Slowing Down a Race Car Headed Toward a Cliff
AMA #43: Understanding apoB, LDL-C, Lp(a), and insulin as risk factors for cardiovascular disease
AMA #43: Understanding apoB, LDL-C, Lp(a), and insulin as risk factors for cardiovascular disease - Peter Attia
4 of 11
right arrow
AMA #43: Understanding apoB, LDL-C, Lp(a), and insulin as risk factors for cardiovascular disease - Peter Attia
left arrow
right arrow
2
+
1.0
-
+
1.0
-
0
ms